Mark Velleca, M.D., Ph.D.

Dr. Mark Velleca is CGI’s Founder and Senior Vice-President.  Dr. Velleca brings to the Company more than 15 years of broad-based experience in both basic biomedical research and clinical medicine. Since the Company's formation, he has played a leading role in the design and implementation of CGI’s scientific strategy for drug discovery and development. Prior to joining CGI Pharmaceuticals, Dr. Velleca was on the faculty of Yale Medical School and the recipient of a NIH Physician/Scientist Career Award. A board-certified clinical pathologist, he has expertise in the laboratory diagnosis of autoimmune/inflammatory diseases, hematological disorders and cancer, as well as the treatment of cancer patients via stem cell transplantation. He has published papers in diverse areas of cell and molecular biology, signal transduction, immunology, neuroscience, and transfusion medicine. Dr. Velleca earned his B.S. Cum Laude from Yale University and is a graduate of the Medical Scientist Training Program at Washington University, receiving an M.D. and a Ph.D. in the neurosciences. After completing clinical training at Yale New Haven Hospital, where he served as Chief Resident, Dr. Velleca did postdoctoral research in Cell Biology and Immunobiology at Yale Medical School. An attending physician at Yale New Haven Hospital until 2002, Dr. Velleca maintains an adjunct appointment at Yale University as a Clinical Assistant Professor of Laboratory Medicine.